Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin in Asymptomatic Aortic Stenosis
NCT00176410Phase 2Unknown
- Sponsor
- Leipzig University
- Start
- Jan 2003
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in aortic stenosis (AS) comparing Fluvastatin with Placebo (2 arms). Primary endpoints: Progression of calcified aortic stenosis at 24 months, Transthoracic echocardiography parameters at 24 months and 1 more. Status: unknown.
02
Drugs
fluvastatin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT00176410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176410.